Boussard & Gavaudan Investment Management’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-534,259	Closed	-$1.36M	–	108
2023 Q4	$1.36M	Buy	+534,259	New	+$1.24M	0.26%	45

Boussard & Gavaudan Investment Management's SLGC Position: Q1 2024 in Review

Boussard & Gavaudan Investment Management sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 534,259 shares — an estimated $1.36M sold.

Boussard & Gavaudan Investment Management first reported a position in SLGC in Q4 2023 and held it in 1 quarter. The position peaked at $1.36M in Q4 2023. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Boussard & Gavaudan Investment Management reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Boussard & Gavaudan Investment Management sold 534,259 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $1.36M.
Boussard & Gavaudan Investment Management first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2023 and held it in 1 quarter.
Boussard & Gavaudan Investment Management's SomaLogic, Inc. Class A Common Stock position peaked at $1.36M in Q4 2023.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q1 2024, filed 14 May 2024.